Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study.
文献类型：期刊论文
| 作者 | Li, Jin; Qin, Shukui; Wen, Lu; Wang, Junsheng; Deng, Wenying; Guo, Weijian; Jia, Tongfu; Zhao, Qun ; Zhang, Guifang; He, Yifu
|
| 刊名 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 出版日期 | 2021-05-20 |
| 卷号 | 39 |
| ISSN号 | 0732-183X |
| DOI | 10.1200/JCO.2021.39.15_suppl.e16037 |
| 资助项目 | Jiangsu Hengrui Pharmaceuticals Co., Ltd |
| WOS研究方向 | Oncology |
| 语种 | 英语 |
| 出版者 | LIPPINCOTT WILLIAMS & WILKINS |
| WOS记录号 | WOS:000708120301310 |
| 资助机构 | Jiangsu Hengrui Pharmaceuticals Co., Ltd |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/126606]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Tongji Univ, Shanghai East Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China 2.Jinling Hosp, PLA Canc Ctr Nanjing, Nanjing, Peoples R China 3.Shanxi Prov Canc Hosp, Dept Gastroenterol, Taiyuan, Peoples R China 4.Anyang Canc Hosp, Dept Internal Med, Anyang, Peoples R China 5.Zhengzhou Univ, Dept Gastroenterol, Affiliated Canc Hosp, Zhengzhou, Peoples R China 6.Henan Canc Hosp, Zhengzhou, Peoples R China 7.Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China 8.ZiBo Cent Hosp, Dept Oncol, Zibo, Peoples R China 9.Hebei Med Univ, Dept Surg, Hosp 4, Shijiazhuang, Hebei, Peoples R China 10.Hebei Canc Hosp, Shijiazhuang, Hebei, Peoples R China |
| 推荐引用方式 GB/T 7714 | Li, Jin,Qin, Shukui,Wen, Lu,et al. Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study.[J]. JOURNAL OF CLINICAL ONCOLOGY,2021,39. |
| APA | Li, Jin.,Qin, Shukui.,Wen, Lu.,Wang, Junsheng.,Deng, Wenying.,...&Sun, Ying.(2021).Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study..JOURNAL OF CLINICAL ONCOLOGY,39. |
| MLA | Li, Jin,et al."Clinical effectiveness of apatinib at different doses in patients with advanced gastric cancer as the third-line or further treatment: Results from a post-marketing phase IV study.".JOURNAL OF CLINICAL ONCOLOGY 39(2021). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。